← All organizations
Highest phase reached
Phase 4
Timeline
1990s
- Jun 1, 1999
Cumberland Pharmaceuticals— Founded
2000s
- Jan 23, 2004
acetylcysteine— NDA Secondary Org
2010s
- Feb 8, 2011
procaine benzylpenicillin— Marketing Organization
Drugs by trial phase (14 distinct, 51 trials)
Phase 4 (9 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Asthma, Aspirin-Induced
- Autoimmune Diseases
- Birth Weight
- Burns
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Connective Tissue Diseases
- Constipation
- Drug Overdose
- Ductus Arteriosus, Patent
- Dyslipidemias
- Emergencies
- Fever
- Fibrosis
- Heart Failure
- Hemorrhage
- Hepatorenal Syndrome
- Hypercholesterolemia
- Hypertension
- Hypertension, Portal
- Hyponatremia
- Intracranial Hemorrhages
- Kidney Diseases
- Liver Cirrhosis
- Liver Diseases
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Neoplasms
- Obesity
- Pathologic Processes
- Pelvic Pain
- Postoperative Pain
- Recurrence
- Respiration Disorders
- Respiratory Tract Diseases
- Scleroderma, Diffuse
- Scleroderma, Limited
- Scleroderma, Localized
- Scleroderma, Systemic
- Sclerosis
- Skin Diseases
- Syndrome
Marketed drugs (11)
Recent trials (50)
- NCT06119061CollaboratorPhase 4Nov 30, 2023
- NCT05571059Overall official - principal investigatorPhase 2Mar 31, 2023
- NCT05571059Lead sponsorPhase 2Mar 31, 2023
- NCT03962855CollaboratorPhase 2Jul 31, 2019
- NCT03694249CollaboratorPhase 2Dec 12, 2018
- NCT03340675Lead sponsorPhase 2Nov 30, 2018
- NCT03611010Lead sponsorPhase 2Aug 7, 2018
- NCT02583399Lead sponsorPhase 4Jun 30, 2017
- NCT03028350Lead sponsorPhase 2Jun 30, 2017
- NCT02802228Lead sponsorPhase 2Mar 6, 2017
- NCT02682511Lead sponsorPhase 2Jan 1, 2017
- NCT02216357Lead sponsorPhase 2Aug 1, 2014
- NCT02123017Lead sponsorPhase 2Apr 1, 2014
- NCT01887470Lead sponsorPhase 2Jul 1, 2013
- NCT01901393Study directorPhase 4Jul 1, 2013
Details
- Founded
- Nashville, TN, US Jun 1, 1999
- Last known activity
- Nov 30, 2023